Once daily Narlaprevir ( SCH 900518 ) in combination with PEGINTRON™ (Peginterferon alfa - 2b ) /Ribavirin for treatment - naïve subjects with genotype - 1 CHC: Interim results from NEXT - 1, a phase 2a study
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.